« Previous Abstract"Source Apportionment of Ambient Methane Enhancements in Los Angeles, California, To Evaluate Emission Inventory Estimates"    Next AbstractVolatile biomarkers from human melanoma cells »

Curr Pharm Biotechnol

Title:		Volatile disease biomarkers in breath: a critique
Author(s):		Kwak J; Preti G;
Address:		"Monell Chemical Senses Center, 3500 Market Street, Philadelphia, PA 19104, USA. jkwak@monell.org"
Journal Title:		Curr Pharm Biotechnol
Year:		2011
Volume:		12
Issue:		7
Page Number:		1067 - 1074
DOI:		10.2174/138920111795909050
ISSN/ISBN:		1873-4316 (Electronic) 1389-2010 (Linking)
Abstract:		"Hundreds of volatile organic compounds (VOCs) are released from human body fluids. Some of them are produced by endogenous metabolic processes in and on the body, and others are derived from the environment. Expressions of some endogenous VOCs can be affected by pathophysiological changes, and several disease-specific volatile biomarkers have been identified and used as diagnostic aids. Monitoring volatile disease markers is attractive since the procedure can be performed in a noninvasive manner with little or no exposure to biohazardous body fluids. Although many VOCs have been claimed as potential biomarkers, only a few compounds have been consistently demonstrated and approved for clinical applications. This is mainly because (1) many of the putative markers are present in the environment as well as in the body and their levels in the environment are often higher than those in the body, (2) there are a large individual variation in the concentrations of biomarkers within diseased and/or healthy subjects, and (3) the origin and biosynthetic pathway of the claimed biomarkers have been frequently neglected. Unfortunately, these aspects have often been ignored in many studies. Here, we review a number of publications that have identified volatile disease biomarkers in breath, argue that many of these have not demonstrated to actually underlie the differences in volatile profiles between diseased patients and healthy subjects, speculate on the reasons for this lack of success, and suggest potential approaches that may provide a better chance of identifying disease biomarkers"
Keywords:		"Animals Biomarkers/*analysis Breath Tests/*methods Diagnosis, Computer-Assisted/*methods Humans Volatile Organic Compounds/*analysis;"
Notes:		"MedlineKwak, Jae Preti, George eng Review Netherlands 2011/04/07 Curr Pharm Biotechnol. 2011 Jul; 12(7):1067-74. doi: 10.2174/138920111795909050"